Clinical Trials Detalhe

This is a randomized clinical trial, aimed to analyse the effects of a potentially anti-inflammatory nutritional intervention in disease assessment parameters, inflammatory markers, and quality of life of Fibromyalgia patients. Patients in the intervention group will adopt an anti-inflammatory diet and a diet with a low ingestion of fermentable oligo-, di- and monosaccharides, and polyols (FODMAPs), for a 3 months period. Group control will adopt a diet based on general recommendations for healthy eating in accordance with the World Health Organization.

Fibromyalgia

Inclusion Criteria: * Diagnosis of FM performed by the physician, according to the Rome III criteria of the American College of Rheumatology, revised in 2010; * Ability to read and sign the Informed Consent; * Stable dose therapy within 4 weeks before study start. Exclusion Criteria: * Patients with pathologies that prevent the follow-up of the given dietary protocol; * Patients currently undergoing lactation or pregnancy; * Prior or current clinical history of abuse of drug or other substances; * Change of therapy during the intervention period; * Presence of other inflammatory diseases; * Uncontrolled medical conditions (eg. Diabetes Mellitus, decompensated heart disease, renal failure, neoplastic diseases, liver diseases).